This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Updated from 2:36 p.m.

Shares of Nephros (NEP - Get Report) jumped 94% after the company said its OLpur HD190 high-flux filter received U.S. marketing clearance for its treatment of kidney disease. "This approval marks the beginning of our move into the U.S., and we believe this approval should also simplify and accelerate the 510(k) approval process for our MD190 and H2H products," said CEO Norman Barta. The stock closed up $1.96 to $4.04.

Shares of American Shared Hospital Services (AMS - Get Report) rose 1.9% after the medical services provider's board boosted its dividend by 5.6%, to 4.75 cents. The dividend will be payable on July 15 to shareholders of record July 1. The stock was up 12 cents to $6.28.

Shares of Vertex Pharmaceuticals (VRTX - Get Report) rose 9.7% after it and Merck (MRK - Get Report) started an additional Phase I clinical study with VX-680, a small molecule inhibitor of Aurora kinases. The two-part, open-label study is designed to evaluate the safety and tolerability of the drug when administered over a five-day treatment cycle in patients with hematologic cancers. Merck and Vertex now have three clinical studies underway with VX-680 in cancer. Vertex finished up $1.35 to $15.30, while Merck closed up 22 cents to $32.22.

Shares of Novo Nordisk (NVO - Get Report) rose 2.9% after the Food and Drug Administration cleared the use of Levemir for the treatment of type 1 and type 2 diabetes. Levemir is a long-lasting form of insulin that provides up to 24-hour action and causes little weight change, according to the company. The company also said that a New Drug Application for Levemir for pediatric indication is currently under review by the FDA. The stock finished up $1.49 to $51.75.

Other health stocks on the move were Abbott Labs (ABT - Get Report), up 35 cents to $49.43; Biogen Idec (BIIB), down 31 cents to $35.94; Elan (ELN), down 8 cents to $6.94; Pfizer (PFE), up 18 cents to $28.78; and Nitromed (NTMD), up 32 cents to $19.73.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABT $38.90 0.00%
AMS $2.02 0.00%
NVO $55.79 0.00%
NEP $28.89 0.00%
MRK $54.84 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs